home / stock / ettx / ettx message board
Subject | By | Source | When |
---|---|---|---|
Yes...keep an eye on this for a later | Pedro2004 | investorshub | 10/19/2021 2:30:34 PM |
Ok that explains the $1 dollar fall from | swampboots | investorshub | 10/19/2021 1:58:35 PM |
We have entered into an Controlled Equity Offering | Pedro2004 | investorshub | 10/19/2021 1:09:33 PM |
$ETTX $+ data confirms, what is addressable market? | swampboots | investorshub | 10/18/2021 8:39:15 PM |
New reddit group talking only about $ETTX. | frugalNorwegian | investorshub | 08/20/2021 8:37:29 PM |
Very cool. I took my eyes off this | BooDog | investorshub | 06/14/2021 10:53:18 AM |
Ya Baby! | Snug Harbour | investorshub | 06/12/2021 2:25:50 PM |
2.73 high, who knew | BooDog | investorshub | 12/23/2020 8:06:09 PM |
Interesting looking charts. Something cooking here? | BooDog | investorshub | 12/16/2020 5:59:44 PM |
In 1.85 this morning pre market. See | BooDog | investorshub | 12/11/2020 2:45:18 PM |
Super odd, they're selling the stocks and warrants | Sluicebox | investorshub | 10/20/2020 2:02:12 PM |
doing a little digging...........the prospectus filed a few | dirtydozen911 | investorshub | 10/16/2020 12:32:11 PM |
offering announced 3 days ago.....prob get hit with | dirtydozen911 | investorshub | 10/16/2020 11:02:45 AM |
Great buying opportunity here close at ATL ,,,dirt | Covid19freak | investorshub | 10/02/2020 11:51:28 AM |
This is awesome. Trusted the model and averaged | swingingRichard | investorshub | 07/16/2020 5:12:33 PM |
$ETTX Sold too early. Made only %28. The | swingingRichard | investorshub | 07/16/2020 5:08:47 PM |
Dirt cheap biotech gem | BioSpecialist | investorshub | 06/18/2020 3:35:52 PM |
($ETTX-DD) Low Valuation of $86 Million / STRONG | BioSpecialist | investorshub | 06/16/2020 7:07:48 PM |
Big move coming here $IMO Giddy up ETTX | Wild Wild West | investorshub | 06/16/2020 4:16:07 AM |
News, Short Squeeze, Breakout and More Instantly...
Entasis Therapeutics Holdings Inc. Company Name:
ETTX Stock Symbol:
NASDAQ Market:
Entasis Therapeutics Holdings Inc. Website:
WALTHAM, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, and wholly owned subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced ...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”) at a price of $2.20 per share, net to the s...
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations at the American Society...